Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 34473262.
- Also identified by DOI 10.1001/jamanetworkopen.2021.24331 and PMC identifier 8414189.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study compares antibody responses in a cohort in which both BNT162b2 and mRNA-1273 COVID-19 vaccines were administered.
Medical subject headings
- Antibody Formation
- COVID-19
- COVID-19 Vaccines